Citius Pharmaceuticals, Inc. Income (Loss) from Equity Method Investments
Citius Pharmaceuticals, Inc. (CTXR) reported Income (Loss) from Equity Method Investments of $110.21 thousand for the 9-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2021-12-15
- Citius Pharmaceuticals, Inc. income (loss) from equity method investments for the quarter ending 2020-12-31 was $110.21K.
- Citius Pharmaceuticals, Inc. income (loss) from equity method investments for fiscal 2020 was $110.21K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2021-06-30 | $110.21K 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $110.21K 10-Q · filed 2021-02-11 | |||
| 2020-09-30 | $110.21K 10-K · filed 2021-12-15 | |||
| 2020-03-31 | $110.21K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |